HUMA is trading at $0.71 (+5.46%) in after-hours trading following a volatile regular session.
- No company-specific catalysts, earnings reports, or major announcements were identified for Humacyte on July 1.
- The price action appears to be a technical bounce characteristic of low-priced, high-volatility stocks rather than a direct response to fresh fundamentals.